TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30796762

Group type: EXPERIMENTAL
Intervention: 1% Moringa oleifera leaves meal (MLM)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: 2% Olea europaea leaves meal (OLM)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Phytogenic plant diets (various treatments)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Commercial diet (control)
Number of subjects: 315
Study: 29805491

Group type: EXPERIMENTAL
Intervention: Intravenous corticosteroid treatment (methylprednisolone)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid treatment (budesonide)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no corticosteroid treatment)
Number of subjects: 120
Study: 27139820

Group type: EXPERIMENTAL
Intervention: Cabozantinib tablet formulation (140 mg)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Cabozantinib tablet strengths (20, 40, and 60 mg)
Number of subjects: 98
Study: 24673043

Group type: EXPERIMENTAL
Intervention: Ear acupuncture group (group C)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Restore interaction between the heart and the kidney group (group A)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Acupuncturing qiao mai group (group B)
Number of subjects: 96
Study: 21870127

Group type: EXPERIMENTAL
Intervention: Training with LLLT (TLG)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Training group (TG)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Training with LLLT group (TLG)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 45
Study: 20238203

Group type: EXPERIMENTAL
Intervention: Prophylactic prosthetic mesh placed in a sublay position at the index operation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic mesh in an onlay position
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic mesh in a sublay position
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic mesh in an intraperitoneal onlay position
Number of subjects: 0
Study: 17341394

Group type: EXPERIMENTAL
Intervention: New left bundle branch block (LBBB)
Number of subjects: 14703

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 14703

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 14703

Group type: COMPARATOR
Intervention: Both valsartan and captopril
Number of subjects: 14703
Study: 16262739

Group type: EXPERIMENTAL
Intervention: PermaNet 1.0
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Insector
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Olyset
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Dawa
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Cyclodextrin-treated nets
Number of subjects: 177

Group type: COMPARATOR
Intervention: Conventional polyester bednets treated with deltamethrin
Number of subjects: 177
Study: 12040355

Group type: EXPERIMENTAL
Intervention: Fenoldopam mesylate at 0.1 microg/kg/min
Number of subjects: 45

Group type: COMPARATOR
Intervention: Normal saline solution (1/2 NS)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Fenoldopam mesylate
Number of subjects: 45

Group type: COMPARATOR
Intervention: Normal saline solution (1/2 NS) in patients with diabetes
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Fenoldopam mesylate in patients with diabetes
Number of subjects: 45
Study: 10069278

Group type: EXPERIMENTAL
Intervention: Cisatracurium (groups 1 and 2)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Vecuronium (groups 3 and 4)
Number of subjects: 79
Study: 8625180

Group type: COMPARATOR
Intervention: Postoperative radiotherapy, 60 Gy in 6 weeks (radiotherapy group)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Three courses of postoperative COPAC chemotherapy followed by similar radiotherapy schedule (chemotherapy/radiotherapy group)
Number of subjects: 267
Study: 2044419

Group type: EXPERIMENTAL
Intervention: Routine sonography at postoperative days 1, 3, 7, and 9
Number of subjects: 300

Group type: COMPARATOR
Intervention: Sonography on demand
Number of subjects: 300
Study: 6797085

Group type: EXPERIMENTAL
Intervention: Aerosol agents (specific agents not detailed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parasympathetic system blocker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta 2 adrenergic stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Histamine-induced bronchial hyperreactivity
Number of subjects: 0
Study: 30719237

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Waiting List (WL)
Number of subjects: 155
Study: 27989690

Group type: EXPERIMENTAL
Intervention: Tadalafil (40mg daily for six weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 25496958

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS applied to the left dorsolateral prefrontal cortex (dlPFC) during a Go/No-Go test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 0
Study: 25233656

Group type: EXPERIMENTAL
Intervention: Hegu 1 group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hegu 2 group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hegu 3 group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hegu 4 group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 22586334

Group type: EXPERIMENTAL
Intervention: Smoked cannabis (once daily for three days)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Identical placebo cigarettes (once daily for three days)
Number of subjects: 37
Study: 20853602

Group type: EXPERIMENTAL
Intervention: Cytosine arabinoside in high doses (first and second course)
Number of subjects: 631

Group type: COMPARATOR
Intervention: Standard induction courses
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: HAM course as the second induction course
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Aggressive therapy
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Platelet transfusion
Number of subjects: 631

Group type: COMPARATOR
Intervention: Induction courses
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Current AML treatment programs
Number of subjects: 631
Study: 17984737

Group type: EXPERIMENTAL
Intervention: Aminophylline (375 mg infusion)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 141
Study: 15338100

Group type: EXPERIMENTAL
Intervention: Diazepam 2.5 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Final challenge with diazepam
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Chronic treatment with diazepam
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: GAD status
Number of subjects: 100
Study: 12191668

Group type: EXPERIMENTAL
Intervention: Total etching + two coats of single bond (SB) + composite resin (Z‐100)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Enamel etching + two coats of SB + Z‐100
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cavity floor lined with calcium hydroxide liner (Dycal) + acid‐etching of enamel and lateral walls + two coats of SB + Z‐100
Number of subjects: 18

Group type: COMPARATOR
Intervention: Intact control group (two teeth)
Number of subjects: 18
Study: 9791745

Group type: EXPERIMENTAL
Intervention: Morning SSR testing
Number of subjects: 10

Group type: COMPARATOR
Intervention: Early evening SSR testing
Number of subjects: 10
Study: 8561981

Group type: EXPERIMENTAL
Intervention: Structured intervention program (individual counseling with a nurse and six-session support group)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Community referral group
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Both groups (structured intervention and community referral)
Number of subjects: 271
Study: 2091337

Group type: EXPERIMENTAL
Intervention: Artemisinine suppositories
Number of subjects: 62

Group type: COMPARATOR
Intervention: Oral quinine
Number of subjects: 62
Study: 7388278

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen with radiotherapy (27 fractions)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Radiotherapy (27 fractions)
Number of subjects: 116
Study: 31811613

Group type: EXPERIMENTAL
Intervention: Culturally tailored couples-based smoking cessation intervention
Number of subjects: 0
Study: 31530608

Group type: EXPERIMENTAL
Intervention: Usual care plus intervention (community midwives weighing women, setting weight gain limits, providing feedback)
Number of subjects: 656

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: Usual care plus intervention
Number of subjects: 656
Study: 27662551

Group type: EXPERIMENTAL
Intervention: Oral pentavalent rotavirus vaccine (RV5)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 25572383

Group type: EXPERIMENTAL
Intervention: Preload dependence indices-guided intravascular volume expansion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Central venous pressure-guided intravascular volume expansion (Control)
Number of subjects: 60
Study: 23323672

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRI) added to supportive care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 0
Study: 17550491

Group type: EXPERIMENTAL
Intervention: 200 microg vaginal misoprostol every six hours up to four doses
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 400 microg vaginal misoprostol every six hours up to four doses
Number of subjects: 100
Study: 15474274

Group type: EXPERIMENTAL
Intervention: Pelvicol pubovaginal sling
Number of subjects: 142

Group type: COMPARATOR
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 142
Study: 10781464

Group type: EXPERIMENTAL
Intervention: Sufentanil 5 microg combined with midazolam 1 mg
Number of subjects: 0
Study: 8757561

Group type: EXPERIMENTAL
Intervention: Cholestyramine (8 gm)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 1550481

Group type: EXPERIMENTAL
Intervention: Methylprednisolone sodium succinate 90 minutes before surgery plus intraoperative neural blockade, with a postoperative analgesic regimen with combined bupivacaine hydrochloride‐morphine and indomethacin sodium (group 2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional postoperative pain treatment with morphine chloride and acetaminophen (group 1)
Number of subjects: 20
Study: 2863443

Group type: EXPERIMENTAL
Intervention: Elective testicular biopsy during chemotherapy
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: End-of-therapy testicular biopsy
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Negative biopsy findings 12-28 months before relapse
Number of subjects: 238
Study: 31816447

Group type: EXPERIMENTAL
Intervention: Trunk Aesthetic Clinical Evaluation (TRACE)
Number of subjects: 1553
Study: 30609310

Group type: EXPERIMENTAL
Intervention: MT medialization
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intact MT
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Patent OC
Number of subjects: 80

Group type: COMPARATOR
Intervention: Congested OC
Number of subjects: 80
Study: 27296243

Group type: EXPERIMENTAL
Intervention: Conversation Therapy (CT)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Stimulation Therapy (ST)
Number of subjects: 2
Study: 25906556

Group type: EXPERIMENTAL
Intervention: Cross electro‐nape‐acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 60
Study: 23688830

Group type: EXPERIMENTAL
Intervention: Clinician-guided Internet-delivered cognitive behaviour therapy (iCBT) program (the Pain Course) consisting of 5 lessons, homework tasks, additional resources, and weekly contact from a Clinical Psychologist.
Number of subjects: 63

Group type: COMPARATOR
Intervention: Waitlist Control Group
Number of subjects: 63
Study: 20824758

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 810

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 810
Study: 19474685

Group type: EXPERIMENTAL
Intervention: Gastric bypass surgery (GBP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Diet
Number of subjects: 30
Study: 16765589

Group type: EXPERIMENTAL
Intervention: CMF chemotherapy (cyclophosphamide, methotrexate, and 5-fluorouracil)
Number of subjects: 771

Group type: COMPARATOR
Intervention: Goserelin (every 28 days for 2 years)
Number of subjects: 771

Group type: EXPERIMENTAL
Intervention: CMF chemotherapy
Number of subjects: 771

Group type: COMPARATOR
Intervention: Goserelin
Number of subjects: 771
Study: 15218709

Group type: EXPERIMENTAL
Intervention: Test dentifrice containing 5.5% potassium citrate, 1.14% sodium monofluorophosphate, and 10% high-cleaning silica
Number of subjects: 80

Group type: COMPARATOR
Intervention: Positive control dentifrice containing 3.75% potassium chloride, 0.32% sodium fluoride, and 0.3% triclosan
Number of subjects: 80
Study: 10899409

Group type: EXPERIMENTAL
Intervention: Caucasian dataset with CATD polymorphism
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Hispanic dataset with CATD polymorphism
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Aggregate analysis of published Caucasian datasets
Number of subjects: 210
Study: 10023151

Group type: EXPERIMENTAL
Intervention: Polarizing mixture (potassium + insulin + glucose)
Number of subjects: 36
Study: 8453222

Group type: EXPERIMENTAL
Intervention: Hypotonic ORS solution (224 mosmol/l)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Isotonic ORS solution (304 mosmol/l)
Number of subjects: 238
Study: 3020732

Group type: EXPERIMENTAL
Intervention: Fish oil supplement (MaxEPA) 15 gm per day
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 31689510

Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) with mechanical debridement (MD) (Group-A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systemic antibiotics (AB) with mechanical debridement (MD) (Group-B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mechanical debridement alone (MD) (Group-C)
Number of subjects: 0
Study: 30301642

Group type: EXPERIMENTAL
Intervention: Pre-vaccine Exercise (15-minutes upper body exercise)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Pre-vaccine Arm, Pre-vaccine Leg, Post-vaccine Arm (15-minutes of arm or leg exercises)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 194
Study: 26510574

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy administered to the dorsum of the tongue
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Treatment with a tongue scraper
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Treatment with a tongue scraper combined with photodynamic therapy
Number of subjects: 45
Study: 24829952

Group type: EXPERIMENTAL
Intervention: Depression-anxiety factor
Number of subjects: 1070

Group type: EXPERIMENTAL
Intervention: Sexual problems due to ADT side effects (breast changes and hot flushes)
Number of subjects: 1070

Group type: EXPERIMENTAL
Intervention: Urinary dysfunction
Number of subjects: 1070

Group type: EXPERIMENTAL
Intervention: Depression-anxiety
Number of subjects: 1070
Study: 21564154

Group type: EXPERIMENTAL
Intervention: Exercise plus usual treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual treatment
Number of subjects: 40
Study: 21335296

Group type: EXPERIMENTAL
Intervention: Community pharmacy-based falls-prevention program (medication consultation)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control group (no medication consultation)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Community pharmacy-based falls-prevention program
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 186
Study: 18347922

Group type: EXPERIMENTAL
Intervention: Self-reported history of lobular proliferation (BBD)
Number of subjects: 6926

Group type: EXPERIMENTAL
Intervention: Self-reported history of fibroadenoma (BBD)
Number of subjects: 6926

Group type: EXPERIMENTAL
Intervention: Self-reported history of other BBD
Number of subjects: 6926

Group type: COMPARATOR
Intervention: Surgically treated fibroadenoma
Number of subjects: 6926

Group type: COMPARATOR
Intervention: Surgically treated other BBDs
Number of subjects: 6926
Study: 15709083

Group type: EXPERIMENTAL
Intervention: Dislike of school
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ambivalence to school
Number of subjects: 0
Study: 12612387

Group type: EXPERIMENTAL
Intervention: iopamidol 340 (Niopam)
Number of subjects: 2108

Group type: EXPERIMENTAL
Intervention: iomeprol 350 (Iomeron)
Number of subjects: 2108

Group type: EXPERIMENTAL
Intervention: iodixanol 320 (Visipaque)
Number of subjects: 2108

Group type: COMPARATOR
Intervention: All agents
Number of subjects: 2108
Study: 10321505

Group type: EXPERIMENTAL
Intervention: 3.75 mg of leuprolide acetate every month
Number of subjects: 50

Group type: COMPARATOR
Intervention: 11.25 mg of leuprolide acetate every 3 months
Number of subjects: 50
Study: 8909627

Group type: EXPERIMENTAL
Intervention: BrainPower Program (attribution retraining program)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Attention training
Number of subjects: 384

Group type: COMPARATOR
Intervention: No-attention control group
Number of subjects: 384
Study: 1958387

Group type: EXPERIMENTAL
Intervention: Immunohistochemical estimate of ER
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Dextran-coated charcoal assay (DCC)
Number of subjects: 349

Group type: COMPARATOR
Intervention: Adjuvant tamoxifen (TAM) treatment
Number of subjects: 349
Study: 6347013

Group type: EXPERIMENTAL
Intervention: Split skin grafting
Number of subjects: 10

Group type: COMPARATOR
Intervention: Silastic foam dressing (healing by granulation)
Number of subjects: 10
Study: 31390370

Group type: EXPERIMENTAL
Intervention: Genetic liability to endometriosis
Number of subjects: 22406

Group type: EXPERIMENTAL
Intervention: Lifetime smoking exposure
Number of subjects: 22406

Group type: EXPERIMENTAL
Intervention: Height
Number of subjects: 22406

Group type: EXPERIMENTAL
Intervention: Age at natural menopause
Number of subjects: 22406

Group type: EXPERIMENTAL
Intervention: Genetic liability to polycystic ovary syndrome
Number of subjects: 22406
Study: 27543681

Group type: EXPERIMENTAL
Intervention: Single-Bundle (SB) techniques (n = 12; all-inside arthroscopic inlay, all-inside suspensory fixation, and arthroscopic-assisted open onlay)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Double-Bundle (DB) techniques (n = 8; arthroscopic-assisted open inlay and all-inside suspensory fixation)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intact knees
Number of subjects: 20
Study: 26258860

Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise training (4-6 months)
Number of subjects: 1188
Study: 23943256

Group type: EXPERIMENTAL
Intervention: Conventional restorative treatment (CRT) using amalgam
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) using high-viscosity glass ionomer
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Ultraconservative treatment (UCT) protocol
Number of subjects: 302
Study: 22873013

Group type: EXPERIMENTAL
Intervention: TND Only
Number of subjects: 1426

Group type: EXPERIMENTAL
Intervention: TND and motivational interviewing follow‐up
Number of subjects: 1426

Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 1426
Study: 19254337

Group type: EXPERIMENTAL
Intervention: Chronic Low Back Pain (CLBP)
Number of subjects: 288
Study: 17302651

Group type: EXPERIMENTAL
Intervention: Structured telephone geriatric assessment by a physician assistant, individualized referrals and recommendations, selected referral to outpatient geriatric assessment, and ongoing telephone case management.
Number of subjects: 792

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 792
Study: 15220164

Group type: EXPERIMENTAL
Intervention: CSL 30 ml kg(-1)
Number of subjects: 141
Study: 11588120

Group type: EXPERIMENTAL
Intervention: BQ-123 100 nmol min(‐1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: BQ-123 300 nmol min(‐1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: BQ-123 1000 nmol min(‐1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: BQ-123 3000 nmol min(‐1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9564607

Group type: EXPERIMENTAL
Intervention: Tranylcypromine
Number of subjects: 37
Study: 7817627

Group type: EXPERIMENTAL
Intervention: Swiss HIV Cohort Study (SHCS)
Number of subjects: 6253
Study: 3354545

Group type: EXPERIMENTAL
Intervention: Staff training in procedures to reduce transmission of infectious diarrhea
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Active surveillance
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no staff training)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Biweekly family-based surveys
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: One-time staff training without subsequent monitoring
Number of subjects: 21
Study: 31453902

Group type: EXPERIMENTAL
Intervention: Anterograde technique
Number of subjects: 44

Group type: COMPARATOR
Intervention: Retrograde technique
Number of subjects: 44
Study: 31504139

Group type: EXPERIMENTAL
Intervention: Ado-trastuzumab emtansine (T-DM1) at 3.6 mg/kg intravenously every 3 weeks until toxicity or disease progression
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ado-trastuzumab emtansine (T-DM1)
Number of subjects: 36
Study: 28454060

Group type: EXPERIMENTAL
Intervention: Heated humidified high-flow nasal cannula oxygen (HHFNC O2)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional O2 therapy (control)
Number of subjects: 51
Study: 26409117

Group type: EXPERIMENTAL
Intervention: Gastroretentive gabapentin (G-GR, 1800 mg)
Number of subjects: 546